Longeveron (LGVN) Research & Development (2020 - 2026)

Longeveron (LGVN) recorded quarterly Research & Development of $2.3 million in Q1 2026, down 14.74% quarter-over-quarter from $2.7 million in Q4 2025, and down 7.79% on a YoY basis from $2.5 million in Q1 2025.

Longeveron (LGVN) Research & Development (2020 - 2026) Analysis & Trends

Longeveron's Research & Development history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.

  • In Q1 2026, Research & Development fell 7.79% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $11.8 million (up 40.48% YoY), while the FY2025 annual figure was $12.0 million, up 47.98% from the prior year.
  • Research & Development was $2.3 million for Q1 2026 at Longeveron, down from $2.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.9 million in Q3 2025 to a low of $1.3 million in Q1 2022.
  • Historically, Research & Development has averaged $2.4 million across 5 years, with a median of $2.3 million in 2023.
  • Biggest YoY gain for Research & Development was 115.17% in 2023; the steepest drop was 37.74% in 2023.
  • A 5-year view of Research & Development shows it stood at $3.3 million in 2022, then slumped by 33.93% to $2.2 million in 2023, then declined by 7.75% to $2.0 million in 2024, then soared by 36.75% to $2.7 million in 2025, then fell by 14.74% to $2.3 million in 2026.
  • The last three Research & Development figures came in at $2.3 million (Q1 2026), $2.7 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 2.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.32 Mn
Dec 31, 2025 2.72 Mn
Sep 30, 2025 3.85 Mn
Jun 30, 2025 2.95 Mn
Mar 31, 2025 2.52 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 2.21 Mn
Jun 30, 2024 1.72 Mn
Mar 31, 2024 2.22 Mn
Dec 31, 2023 2.16 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 2.29 Mn
Mar 31, 2023 2.78 Mn
Dec 31, 2022 3.26 Mn
Sep 30, 2022 2.96 Mn
Jun 30, 2022 1.72 Mn
Mar 31, 2022 1.29 Mn
Dec 31, 2021 1.73 Mn
Sep 30, 2021 2.05 Mn
Jun 30, 2021 1.96 Mn